ARCHIVES

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

Academic Oncologists Losing Control Over Phase I Trials As For-Profits Expand

March 26, 2010

NCAB Commends Garb for His Contributions

December 11, 1981

Marc Lippman To Leave Georgetown For Michigan To Head Internal Medicine; Five Named To DCLG.

September 15, 2000

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

House Committee Seeks Information on ImClone Insider Stock Trading.

March 29, 2002

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

November 1, 1974